Advertisement
CDT Equity Inc.

CDT Equity Inc. (CDT) Stock Overview

Explore CDT Equity Inc.’s financial performance, market position, analyst ratings, and future outlook.

CDTNASDAQ
HealthcareBiotechnology
$1.02
$0.33(47.19%)
U.S. Market opens in 55h 44m
Advertisement

CDT Equity Inc. (CDT)

Meyka AI Score

Z

Key Financials

Market Cap5M
P/E Ratio0.00
EPS (TTM)$-1177.89
ROE0.03%
Fundamental Analysis

AI Price Forecasts

1 Month$1.29
3 Months$0.00
1 Year Target$0.00

CDT Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of CDT Equity Inc. (CDT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 40.91, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 0.00 and a market capitalization of 5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
47.19%
5-Day Change
41.53%
1-Month Change
-15.00%
3-Month Change
-91.54%
6-Month Change
-97.50%
Year-to-Date (YTD) Change
-96.81%
1-Year Change
-99.78%
3-Year Change
-100.00%
5-Year Change
-100.00%
All-Time (Max) Change
-100.00%

Contact Information

646 491 9132
4581 Tamiami Trail North, Naples, FL, 34103

Company Facts

60 Employees
IPO DateMar 28, 2022
CountryUS
Actively Trading

Frequently Asked Questions